Some updates on CBD’s status at the federal level from Vote Hemp:

“U.S. Senate Majority Leader Mitch McConnell (R-KY) met with Acting Food and Drug Administration (FDA) Commissioner Dr. Ned Sharpless yesterday. During the meeting, Senator McConnell discussed the importance of hemp production and the need for clarity from FDA on the sale of hemp derived CBD products.  Senator McConnell informed Dr. Sharpless of the positive impact the legalization of hemp is having in Kentucky. He also reminded Dr. Sharpless of some of the ongoing challenges — such as the need for a regulatory framework for CBD — he hears about from hemp farmers, processors and manufacturers in the state. “While the 2018 Farm Bill included my provision to remove hemp, and its derivatives like CBD, from the list of controlled substances, CBD food and dietary supplement products remain in a gray area without clarification from the FDA,” Senator McConnell said. “Congress’ intent was clear with the passage of the Farm Bill that these products should be legal, and our farmers, producers and manufacturers need clarity as well as a workable pathway forward regarding the Agency’s enforcement and potential regulatory plans for certain CBD products. I appreciate Acting Commissioner Sharpless meeting with me today to discuss this important issue. Like my constituents, I am anxious to know the FDA’s plans to ensure public access to safe CBD products.”

Leave a Reply